List of works - Lavinia Spain

Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma

article

Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection

article

Combination dabrafenib and trametinib in the management of advanced melanoma with BRAFV600 mutations.

scientific article published on 30 March 2016

Combination immune checkpoint blockade with ipilimumab and nivolumab in the management of advanced melanoma

scientific article

Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma.

scientific article

Determining predictive factors for immune checkpoint inhibitor toxicity: Response to Letter to the Editors "A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome"

scientific article published on 19 May 2016

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

scientific article published on 11 April 2018

Drug fever due to labetalol.

scientific article

Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series.

scientific article published on 12 November 2016

Efficacy of the combination of ipilimumab and nivolumab following progression on pembrolizumab in advanced melanoma with poor risk features

scientific article published on 24 February 2017

Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.

scientific article

How we treat neurological toxicity from immune checkpoint inhibitors

scientific article published on 31 July 2019

Hypertensive crisis precipitated by insulin-induced hypoglycemia with end-stage renal failure.

scientific article published on 7 June 2012

Management of toxicities of immune checkpoint inhibitors.

scientific article published on 06 February 2016

Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature.

scientific article

Pembrolizumab in the management of metastatic melanoma

scientific article published on 12 November 2015

Post-traumatic intercostal liver herniation

scientific article published on 01 July 2008

Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma.

scientific article published on 21 January 2016

Thyroid abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death receptor protein-1 inhibitors in the treatment of melanoma

scientific article published on 27 December 2016

Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study

scientific article published on 30 January 2019

Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal

scientific article published on 4 April 2018

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

scientific article published on 9 April 2018

Weighing up the pros and cons of immune checkpoint inhibitors in the treatment of melanoma

article

List of works by Lavinia Spain

Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma

Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection

Combination dabrafenib and trametinib in the management of advanced melanoma with BRAFV600 mutations.

Combination immune checkpoint blockade with ipilimumab and nivolumab in the management of advanced melanoma

Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma.

Determining predictive factors for immune checkpoint inhibitor toxicity: Response to Letter to the Editors "A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome"

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

Drug fever due to labetalol.

Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series.

Efficacy of the combination of ipilimumab and nivolumab following progression on pembrolizumab in advanced melanoma with poor risk features

Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.

How we treat neurological toxicity from immune checkpoint inhibitors

Hypertensive crisis precipitated by insulin-induced hypoglycemia with end-stage renal failure.

Management of toxicities of immune checkpoint inhibitors.

Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature.

Pembrolizumab in the management of metastatic melanoma

Post-traumatic intercostal liver herniation

Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma.

Thyroid abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death receptor protein-1 inhibitors in the treatment of melanoma

Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study

Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

Weighing up the pros and cons of immune checkpoint inhibitors in the treatment of melanoma